Meta-analysis evaluating the efficacy of sodium-glucose co-transporter-2 inhibitors in subjects with heart failure with preserved left ventricular ejection fraction

Dimitrios Patoulias,Alexandra Katsimardou,Maria Toumpourleka,Ioanna Zografou,Konstantinos Petidis,Konstantinos Imprialos,George Kassimis,Aristi Boulmpou,Christodoulos Papadopoulos,Michael Doumas

JOURNAL OF HYPERTENSION（2022）

引用 0|浏览0

暂无评分

摘要

Current evidence suggests that SGLT-2 inhibitors are also efficacious in HFpEF. Although total mortality was not significantly reduced, the trend towards beneficial effects along with the demonstrated morbidity benefits point towards the use of SGLT-2 inhibitors in this patient population.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要